Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03274778 | Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells | withdrawn | N/A | 0 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06994299 | A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma(PRISM) | withdrawn | Phase 2 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 |
| Nov 18, 2025 |
| clinicaltrials |
| NCT07026916 | A Phase II Study to Evaluate GFH375 in Patients With KRAS G12D Mutant Metastatic Pancreatic Cancer | withdrawn | Phase 2 | 0 | Genfleet Therapeutics (Shanghai) Inc.INDUSTRY | 0 | Nov 17, 2025 | clinicaltrials |
| NCT05904704 | Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors | withdrawn | N/A | 0 | OHSU Knight Cancer InstituteOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT05954676 | Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 0 | Oct 28, 2025 | clinicaltrials |
| NCT05634954 | Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer | withdrawn | Phase 1 | 0 | GE HealthcareINDUSTRY | 1 | Oct 23, 2025 | clinicaltrials |
| NCT05341947 | Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma | withdrawn | Phase 1 | 0 | Jeremy Rudnick, M.DOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT05720624 | Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation | withdrawn | Phase 1 | 0 | Mayo ClinicOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT06060587 | Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone | withdrawn | Phase 2 | 0 | Northwestern UniversityOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT04910425 | PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer | withdrawn | Phase 2 | 0 | Northwestern UniversityOTHER | 1 | Oct 21, 2025 | clinicaltrials |
| NCT05564416 | Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Oct 21, 2025 | clinicaltrials |
| NCT06557278 | Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer(COMUNITY) | withdrawn | Phase 2 | 0 | Mirror Biologics, Inc.INDUSTRY | 1 | Oct 21, 2025 | clinicaltrials |
| NCT02315157 | Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma | withdrawn | Phase 1 | 0 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT04645810 | A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence | withdrawn | N/A | 0 | University of RochesterOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT04419181 | Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer | withdrawn | Phase 2 | 0 | University of RochesterOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT04794816 | What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 14, 2025 | clinicaltrials |
| NCT05483023 | 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy | withdrawn | Phase 2 | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Oct 14, 2025 | clinicaltrials |
| NCT06884254 | Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer.(EGC102) | withdrawn | Phase 3 | 0 | EirGenix, Inc.INDUSTRY | 1 | Oct 14, 2025 | clinicaltrials |
| NCT06386432 | EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico | withdrawn | N/A | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT04036045 | Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity | withdrawn | — | 0 | Connecticut Children's Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT06730100 | CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05774535 | Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery(TIROVASC) | withdrawn | — | 0 | Istituto Auxologico ItalianoOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05754216 | Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve | withdrawn | N/A | 0 | Vanderbilt University Medical CenterOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT05046782 | Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 30, 2025 | clinicaltrials |
| NCT05108233 | Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course | withdrawn | — | 0 | Thomas Jefferson UniversityOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT06527690 | Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer(REPRESENTATION) | withdrawn | Phase 2 | 0 | Latin American Cooperative Oncology GroupOTHER | 0 | Sep 29, 2025 | clinicaltrials |
| NCT02151123 | Metabiomics Colon Cancer Clinical Research Study | withdrawn | — | 0 | Metabiomics CorpINDUSTRY | 1 | Sep 26, 2025 | clinicaltrials |
| NCT03974204 | Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis. | withdrawn | N/A | 0 | Centre Oscar LambretOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT04344652 | Photoscreening for Retinoblastoma | withdrawn | N/A | 0 | Phoenix Children's HospitalOTHER | 0 | Sep 26, 2025 | clinicaltrials |
| NCT06597773 | Online Patient Navigation Program for Patients With Breast Cancer | withdrawn | N/A | 0 | Medicos e Investigadores en la Lucha contra el Cancer de MamaOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT01326468 | Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer | withdrawn | N/A | 0 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 0 | Sep 25, 2025 | clinicaltrials |
| NCT06528210 | Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Sep 23, 2025 | clinicaltrials |
| NCT02869282 | Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer(CHEMOPROST) | withdrawn | — | 0 | Institut BergoniéOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04372641 | Testing the Safety of CB-5339 in Patients With Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04784221 | Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse(NANOPRO) | withdrawn | Phase 2 | 0 | Centre Francois BaclesseOTHER | 0 | Sep 17, 2025 | clinicaltrials |
| NCT06058728 | A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)(Pink Orchid) | withdrawn | — | 0 | AbbVieINDUSTRY | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06670105 | A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06672224 | Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Sep 17, 2025 | clinicaltrials |
| NCT01827969 | Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy(USF) | withdrawn | N/A | 0 | Institut BergoniéOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT05472623 | Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab(Neo-Kan) | withdrawn | Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06746324 | Assessing AI for Detecting Lung Nodules and Cancer: Pre- and Post-Deployment Study(AI-Lung) | withdrawn | — | 0 | University of FloridaOTHER | 0 | Sep 15, 2025 | clinicaltrials |
| NCT00466830 | Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast Cancer(SDPM) | withdrawn | — | — | Institut BergoniéOTHER | 0 | Sep 11, 2025 | clinicaltrials |
| NCT06410534 | A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06690281 | A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Sep 11, 2025 | clinicaltrials |
| NCT00210171 | Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer(BIB 01) | withdrawn | Phase 2 | 0 | Institut BergoniéOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT06276946 | Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia | withdrawn | N/A | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT00210145 | Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer.(ASE K SEIN) | withdrawn | — | 0 | Institut BergoniéOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT04557709 | Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 4, 2025 | clinicaltrials |
| NCT06084689 | Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures(EMPIRE) | withdrawn | Phase 2 | 0 | Institut BergoniéOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT04053114 | MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii(MOLTHYSO) | withdrawn | — | 0 | Institut BergoniéOTHER | 1 | Aug 29, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Nov 18, 2025source: clinicaltrials